Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mezigdomide-A Novel Cereblon E3 Ligase Modulator under Investigation in Relapsed/Refractory Multiple Myeloma. | Cancers (Basel) | 2024 | 38539501 | PubTator, text mining | PubMed |
| A Phase I, Open-Label, Mass Balance Study of [14C]-Iberdomide in Healthy Subjects. | Eur J Drug Metab Pharmacokinet | 2024 | 38521893 | PubTator, text mining | PubMed |
| Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells. | Mol Oncol | 2024 | 38520049 | PubTator, text mining | PubMed |
| The emerging roles of non-canonical ubiquitination in proteostasis and beyond. | J Cell Biol | 2024 | 38517379 | PubTator, text mining | PubMed |
| Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates. | Nat Chem Biol | 2024 | 38514884 | PubTator, text mining | PubMed |
| The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls. | EMBO Mol Med | 2024 | 38514794 | PubTator, text mining | PubMed |
| Proteome-scale discovery of protein degradation and stabilization effectors. | Nature | 2024 | 38509365 | PubTator, text mining | PubMed |
| PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication. | Cell Chem Biol | 2024 | 38508197 | PubTator, text mining | PubMed |
| Cryo-electron microscopy-based drug design. | Front Mol Biosci | 2024 | 38501110 | PubTator, text mining | PubMed |
| Continuous evolution of compact protein degradation tags regulated by selective molecular glues. | Science | 2024 | 38484051 | PubTator, text mining | PubMed |
| Harmony of Protein Tags and Chimeric Molecules Empowers Targeted Protein Ubiquitination and Beyond. | Cells | 2024 | 38474390 | PubTator, text mining | PubMed |
| Corrigendum to "A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer" [Bioorgan. Chem. 119 (2022) 105505]. | Bioorg Chem | 2024 | 38458892 | PubTator, text mining | PubMed |
| Click chemistry in the development of PROTACs. | RSC Chem Biol | 2024 | 38456041 | PubTator, text mining | PubMed |
| Unlocking the Immunomodulatory Potential of Rosmarinic Acid Isolated from Punica granatum L. using Bioactivity-Guided Approach: In Silico, In Vitro, and In Vivo Approaches. | Curr Med Chem | 2024 | 38445701 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity. | Eur J Med Chem | 2024 | 38394929 | PubTator, text mining | PubMed |
| Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators. | RSC Med Chem | 2024 | 38389883 | PubTator, text mining | PubMed |
| Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3. | Mol Ther Nucleic Acids | 2024 | 38384444 | PubTator, text mining | PubMed |
| Expansion of targeted degradation by Gilteritinib-Warheaded PROTACs to ALK fusion proteins. | Bioorg Chem | 2024 | 38377822 | PubTator, text mining | PubMed |
| The cyclimids: Degron-inspired cereblon binders for targeted protein degradation. | Cell Chem Biol | 2024 | 38320555 | PubTator, text mining | PubMed |
| Design, synthesis, and biological characterization of proteolysis targeting chimera (PROTACs) for the ataxia telangiectasia and RAD3-related (ATR) kinase. | Eur J Med Chem | 2024 | 38308949 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=22